CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2015	Sep. 30, 2014
Current assets:
Cash	$ 168,590	$ 6,000
Prepaid expenses	30
Available for sale securities	900,000	$ 1,600,000
Total current assets	1,068,620	1,606,000
Intellectual Property - License	1,609,200	1,549,822
Patent Costs	143,178	143,178
Total assets	2,820,998	3,299,000
Current liabilities:
Accounts payable	171,623	142,000
Accrued expenses - related parties	268,980	$ 24,000
Accrued liabilities	12,575
Total liabilities	$ 453,178	$ 166,000
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Preferred stock, $0.001 par value, 50,000,000 shares authorized; Series B preferred stock, $0.001 par value, 0 and 3,000 issued and outstanding as of March 31, 2015 and September 30, 2014, respectively
Common stock, $0.00001 par value, 450,000,000 shares authorized; 94,228,599 as of March 31, 2015 and 71,656,000 shares issued and outstanding as of September 30, 2014	$ 942	$ 720
Additional paid in capital	10,919,064	10,003,280
Accumulated other comprehensive loss	(1,100,000)	(400,000)
Accumulated deficit	(7,452,186)	(6,471,000)
Total stockholders' equity	2,367,820	3,133,000
Total liabilities and stockholders' equity	$ 2,820,998	$ 3,299,000